Nyt fra tidsskrifterne
Søgeord (rsv) valgt.
54 emner vises.
1
Recent trends in hospitalizations for Respiratory Syncytial Virus after the COVID-19 pandemic and before routine immunization: seasonality and severity updates from the 2023/2024 season in Tuscany, Italy
International Journal of Infectious Diseases
Tilføjet 14.03.2025
2
Clinical phenotypes and outcomes associated with respiratory syncytial virus infection in critically ill patients: a retrospective multicentre cohort study in Great Paris area hospitals, 2017-2023
Journal of Infectious Diseases
Tilføjet 14.03.2025
3
Persistently high burden of acute respiratory infections requiring hospitalization in German pediatric hospitals, fall/winter 2023–2024
Infection
Tilføjet 11.03.2025
4
Decline of community-acquired alveolar pneumonia positive for respiratory syncytial virus in hospitalized children following implementation of PCV in Israel
Clinical Infectious Diseases
Tilføjet 8.03.2025
5
RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021–2023
Infection
Tilføjet 6.03.2025
6
Panoramic quantitative and visualization-based bibliometric analysis of Mycoplasma pneumoniae
Infection
Tilføjet 6.03.2025
7
Prevalence and distribution of respiratory pathogens in pediatric acute respiratory infections in Putian, China
BMC Infectious Diseases
Tilføjet 1.03.2025
8
Health inequalities in respiratory tract infections – beyond COVID-19
Current Opinion in Infectious Diseases
Tilføjet 27.02.2025
9
Microevolution and phylogenomic study of Respiratory Syncytial Virus type A
PLoS One Infectious Diseases
Tilføjet 26.02.2025
10
Retrospective study on the epidemiological characteristics of multi-pathogen infections of hospitalized severe acute respiratory tract infection and influenza-like illness in Xinjiang from January to May 2024
BMC Infectious Diseases
Tilføjet 24.02.2025
11
RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021–2023
Infection
Tilføjet 22.02.2025
12
Bacterial polysaccharide lyase family 33: Specificity from an evolutionarily conserved binding tunnel
Proceedings of the National Academy of Sciences
Tilføjet 20.02.2025
13
Panoramic quantitative and visualization-based bibliometric analysis of Mycoplasma pneumoniae
Infection
Tilføjet 14.02.2025
14
Efficacy, Immunogenicity, and Safety of the Bivalent RSV Prefusion F (RSVpreF) Vaccine in Older Adults Over 2 RSV Seasons
Clinical Infectious Diseases
Tilføjet 10.02.2025
15
Respiratory pathogen spectrum and epidemiological trends in Hainan Province: a retrospective analysis from 2017 to 2023
BMC Infectious Diseases
Tilføjet 10.02.2025
16
RSV‐Bacterial Co‐Infection Is Associated With Increased Illness Severity in Hospitalized Children ‐ Results From a Prospective Sentinel Surveillance Study
Journal of Medical Virology
Tilføjet 9.02.2025
17
Clinical manifestations, para-clinical features and outcome of Iranian adults with respiratory syncytial virus (RSV) infection: a report from hospitalized patients
BMC Infectious Diseases
Tilføjet 9.02.2025
18
Unseasonal respiratory syncytial virus epidemics during the COVID-19 pandemic: relationship between climatic factors and epidemic strain switching
International Journal of Infectious Diseases
Tilføjet 8.02.2025
19
Ten-Year Surveillance of RSV Hospitalizations in Adults: Incidence Rates and Case Definition Implications
Journal of Infectious Diseases
Tilføjet 6.02.2025
20
[Articles] Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021–23)
Lancet Respiratory Medicine
Tilføjet 5.02.2025
21
Antibody Response to RSV Vaccination in Immunocompromised Persons
Journal of the American Medical Association
Tilføjet 4.02.2025
22
Molecular characterization of RSV infections in elderly patients during the 2023/2024 season in the era of nirsevimab introduction
Journal of Infectious Diseases
Tilføjet 3.02.2025
23
Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccine
Clinical Infectious Diseases
Tilføjet 31.01.2025
24
Impact of COVID-19 pandemic measures on hospitalizations and epidemiological patterns of twelve respiratory pathogens in children with acute respiratory infections in southern China
BMC Infectious Diseases
Tilføjet 25.01.2025
25
Respiratory syncytial virus infection in patients with haematological diseases: a retrospective multicentre study
Infection
Tilføjet 24.01.2025
26
Human Metapneumovirus in China: A Wake-Up Call for Resilient Healthcare Systems and Rapid Response
International Journal of Infectious Diseases
Tilføjet 23.01.2025
27
[Articles] Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study
Lancet Infectious Diseases
Tilføjet 21.01.2025
28
A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets
Virulence
Tilføjet 14.01.2025
29
Inpatient service utilization amongst infants diagnosed with Respiratory Syncytial Virus infection (RSV) in the United States
PLoS One Infectious Diseases
Tilføjet 13.01.2025
30
CPS-Ped: A Metric of RSV Severity and Progression in Children
Journal of Infectious Diseases
Tilføjet 11.01.2025
31
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Nature
Tilføjet 10.01.2025
32
Atrial Fibrillation after RSV Vaccination Among Older Adults
Clinical Infectious Diseases
Tilføjet 27.12.2024
33
Amino acid substitutions in the fusion protein of respiratory syncytial virus in Fukushima, Japan during 2008–2023 and their effects
Journal of Infectious Diseases
Tilføjet 26.12.2024
34
Socio-Economic Inequities in the Age-Specific Burden of Severe Respiratory Syncytial Virus (RSV) in Canada, 2016-2019
Journal of Infectious Diseases
Tilføjet 25.12.2024
35
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024
Clinical Microbiology and Infection
Tilføjet 25.12.2024
36
Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody
BMC Infectious Diseases
Tilføjet 19.12.2024
37
RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial
BMC Infectious Diseases
Tilføjet 13.12.2024
38
Influence of COVID-19 public health restrictions on community-acquired pneumonia pathogens in children in Henan, China: a multicenter retrospective study
BMC Infectious Diseases
Tilføjet 13.12.2024
39
Revisiting diagnostics: Multiplex PCR system for rapid diagnosis of respiratory virus infections: can we do better?
Clinical Microbiology and Infection
Tilføjet 12.12.2024
40
Community-Acquired Respiratory Virus Infections: A Threat to Long-Term survivors after Allogeneic Stem Cell Transplant?
Clinical Infectious Diseases
Tilføjet 6.12.2024
41
Lower respiratory tract infections following respiratory syncytial virus monoclonal antibody nirsevimab immunization versus placebo: Analysis from a Phase 3 randomized clinical trial (MELODY)
Clinical Infectious Diseases
Tilføjet 5.12.2024
42
Etiological analysis of acute respiratory infections in hospitalized children after the relaxation of COVID-19 non-pharmacological interventions in Quzhou, China
BMC Infectious Diseases
Tilføjet 30.11.2024
43
An Overview on Disease Burden and Management of Respiratory Syncytial Virus Infections in Older Adults in the Asia‐Pacific Region
Reviews in Medical Virology
Tilføjet 29.11.2024
44
A Phase 1b/2a Single Ascending Dose Study of a Half-life Extended RSV Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants
Journal of Infectious Diseases
Tilføjet 28.11.2024
45
Development of high titer anti-drug antibodies in a Phase 1b/2a infant clesrovimab trial are associated with RSV exposure beyond day 150
Journal of Infectious Diseases
Tilføjet 28.11.2024
46
Molecular characterization of human respiratory syncytial virus strains circulating among hospitalized children in Jordan
BMC Infectious Diseases
Tilføjet 27.11.2024
47
[Articles] Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
Lancet Infectious Diseases
Tilføjet 26.11.2024
48
Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children
Journal of Infectious Diseases
Tilføjet 25.11.2024
49
Cost of delivering childhood RSV prevention interventions to the health system in Kenya: a prospective analysis
BMJ Open
Tilføjet 23.11.2024
50
Epidemiological characteristics of five non-COVID respiratory viruses among 37,139 all-age patients during 2018 − 2023 in Weifang, China: a cross-sectional study
BMC Infectious Diseases
Tilføjet 21.11.2024